Azstarys received FDA approval on January 27, 2021 [1].
When did Azstarys launch in the US?
Following its FDA approval, Azstarys became available in the United States.
What is Azstarys used for?
Azstarys is a prescription medication used to treat Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years and older [1].
How does Azstarys work?
Azstarys is a central nervous system (CNS) stimulant that contains a combination of serdexymethylphenidate (SDX) and dexmethylphenidate [1]. SDX is a prodrug that is converted to dexmethylphenidate in the body. This combination is designed to provide a therapeutic effect throughout the day.
Who makes Azstarys?
Azstarys is manufactured by Corium, Inc., a specialty pharmaceutical company [1].
What is the patent status for Azstarys?
Information regarding the specific patents covering Azstarys and their expiry dates can be found on resources like DrugPatentWatch.com, which tracks drug patents and exclusivity [2].
Are there alternatives to Azstarys for ADHD?
Yes, several other medications are available for the treatment of ADHD. These include other stimulant medications, such as Adderall (amphetamine and dextroamphetamine) and Ritalin (methylphenidate), as well as non-stimulant options.
What is the difference between Azstarys and other methylphenidate medications?
Azstarys is unique because it contains serdexmethylphenidate, a prodrug, in combination with immediate-release dexmethylphenidate. This formulation is designed to provide a different pharmacokinetic profile compared to other methylphenidate-based medications [1].
---
Sources
[1] https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/022530Orig1s000Appv.pdf
[2] https://drugpatentwatch.com/